NCT05280366

Brief Summary

A study of the Streamline Surgical System versus competitor

Trial Health

78
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
1mo left

Started Feb 2022

Longer than P75 for not_applicable

Geographic Reach
3 countries

20 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Feb 2022Jun 2026

First Submitted

Initial submission to the registry

December 29, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

February 9, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 15, 2022

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

November 12, 2024

Status Verified

April 1, 2024

Enrollment Period

4.4 years

First QC Date

December 29, 2021

Last Update Submit

November 7, 2024

Conditions

Keywords

glaucomaGoniotomyMIGS

Outcome Measures

Primary Outcomes (1)

  • Change in mean unmedicated diurnal Intraocular Pressure (IOP)

    Change in mean unmedicated diurnal Intraocular Pressure (IOP) over time

    24 months

Study Arms (2)

Streamline Surgical System

OTHER

Streamline Surgical System procedure administered

Device: Streamline Surgical System

iStent Inject W

ACTIVE COMPARATOR

iStent Inject W implanted

Device: iStent Inject W

Interventions

Completion of the Streamline Surgical System procedure

Streamline Surgical System

Implantation of competitor device

iStent Inject W

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of Mild to Moderate Primary Open Angle Glaucomma

You may not qualify if:

  • Other types of glaucoma including but not limited to: Normal tension glaucoma, pseudoexfoliative glaucoma, narrow angle glaucoma, traumatic, congenital, malignant, uveitic or neovascular glaucoma. Ocular hypertension.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (20)

Vold Vision

Fayetteville, Arkansas, 72704, United States

Location

Visionary Research Institute

Newport Beach, California, 92663, United States

Location

Wolstan and Goldberg Eye Associates

Torrance, California, 90505, United States

Location

University of Colorado

Aurora, Colorado, 80045, United States

Location

Ocala Eye

Ocala, Florida, 34474, United States

Location

Georgia Eye Partners

Atlanta, Georgia, 30342, United States

Location

The Eye Institute

Louisville, Kentucky, 40206, United States

Location

Ophthalmology Associates

St Louis, Missouri, 63131, United States

Location

Eye Associates of North New Jersey

Dover, New Jersey, 07927, United States

Location

Eye Associates Surgical Center

Vineland, New Jersey, 08361, United States

Location

Ross Eye Institute

Orchard Park, New York, 14127, United States

Location

Black Hills Regional Eye Institute

Rapid City, South Dakota, 57701, United States

Location

University Eye Specialists

Maryville, Tennessee, 37003, United States

Location

Ophthalmology Associates

Fort Worth, Texas, 76102, United States

Location

Berkely Eye Center

Houston, Texas, 77027, United States

Location

R & R Eye Research

San Antonio, Texas, 78229, United States

Location

Piedmont Eye Center

Lynchburg, Virginia, 24052, United States

Location

Eye Centers of Racine and Kenosha

Racine, Wisconsin, 53405, United States

Location

Clinica 20/20

San José, 10108, Costa Rica

Location

Clinica Laser y Ultrasonido Ocular

Puebla City, 72530, Mexico

Location

MeSH Terms

Conditions

Glaucoma, Open-AngleGlaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Officials

  • Elysia Ison, OD

    New World Medical, Inc.

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2021

First Posted

March 15, 2022

Study Start

February 9, 2022

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

November 12, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations